Highly-sensitive C-reactive protein, a biomarker of cardiovascular disease risk, in radically-treated differentiated thyroid carcinoma patients after repeated thyroid hormone withholding.

Piciu, A; Piciu, D; Marlowe, R J; Irimie, A

Piciu, A; Piciu, D; Marlowe, R J; Irimie, A.

Affiliation

Piciu A; University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, România.

Exp Clin Endocrinol Diabetes ; 121(2): 102-8, 2013 Feb.

Article in En | MEDLINE | ID: mdl-23426704

Subject(s)

C-Reactive Protein/analysis; Carcinoma/blood; Cardiovascular Diseases/epidemiology; Thyroid Neoplasms/blood; Adult; Age Factors; Antithyroid Agents/adverse effects; Antithyroid Agents/therapeutic use; Biomarkers/blood; Carcinoma/immunology; Carcinoma/pathology; Carcinoma/therapy; Cardiovascular Diseases/etiology; Cardiovascular Diseases/immunology; Cell Transformation, Neoplastic/pathology; Cohort Studies; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Male; Middle Aged; Prospective Studies; Risk; Romania/epidemiology; Thyroid Gland/drug effects; Thyroid Gland/immunology; Thyroid Gland/pathology; Thyroid Gland/surgery; Thyroid Hormones/administration & dosage; Thyroid Hormones/therapeutic use; Thyroid Neoplasms/immunology; Thyroid Neoplasms/pathology; Thyroid Neoplasms/therapy; Thyroidectomy/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: C-Reactive Protein / Thyroid Neoplasms / Carcinoma / Cardiovascular Diseases Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: Europa Language: En Journal: Exp Clin Endocrinol Diabetes Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google